Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency

Clinical trial NCT00125190 · COMPLETED

Trial details

NCT number: NCT00125190
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Insulin-Like Growth Factor-1 Deficiency Growth Disorders

Start date: 2005-07-01
Primary completion: 2009-01-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.